P93 Phase II study of epirubicin and docetaxel asneoadjuvant chemotherapy in patients with large breast cancer (stage II-III, tumor size >3.Ocm). Kyushu ET study group in Japan
R. Nishimura, Y. Raie, S. Mitsuyama, S. Toyoshima, H. Iwasaki, I. Ichinose, K. Tamura, F. Matsuo, S. Hara, N. ItoyanagiVolume:
14
Year:
2005
Language:
english
Pages:
1
DOI:
10.1016/s0960-9776(05)80129-8
File:
PDF, 303 KB
english, 2005